Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126129602 | 12612960 | 2 | F | 20160826 | 20160802 | 20160830 | EXP | PHEH2016US019068 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160830 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126129602 | 12612960 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.062 MG (0.25 ML) QOD | 54223-1A | 125290 | .062 | MG | SOLUTION FOR INJECTION | ||||||
| 126129602 | 12612960 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.125 MG (0.5 ML) QOD | 54223-1A | 125290 | .125 | MG | SOLUTION FOR INJECTION | ||||||
| 126129602 | 12612960 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.187 MG, (0.75 ML) QOD | 54223-1A | 125290 | .187 | MG | SOLUTION FOR INJECTION | ||||||
| 126129602 | 12612960 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.25 MG (1ML), QOD | 54223-1A | 125290 | .25 | MG | SOLUTION FOR INJECTION | ||||||
| 126129602 | 12612960 | 5 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.125 MG (0.5 ML), QOD | 54223-1A | 125290 | .125 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126129602 | 12612960 | 1 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126129602 | 12612960 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126129602 | 12612960 | Asthenia | |
| 126129602 | 12612960 | Chills | |
| 126129602 | 12612960 | Depression | |
| 126129602 | 12612960 | Feeling abnormal | |
| 126129602 | 12612960 | Feeling hot | |
| 126129602 | 12612960 | Gait disturbance | |
| 126129602 | 12612960 | Inappropriate schedule of drug administration | |
| 126129602 | 12612960 | Injection site bruising | |
| 126129602 | 12612960 | Nausea | |
| 126129602 | 12612960 | Pallor | |
| 126129602 | 12612960 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126129602 | 12612960 | 1 | 20160726 | 0 |